Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong Zang

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Sensors (Basel, Switzerland)|June 9, 2018
Cold-Rolled Strip Steel Stress Detection Technology Based on a Magnetoresistance Sensor and the Magnetoelastic EffectBen Guan, Yong Zang, Xiaohui Han, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Characterization of proteoform post-translational modifications by top-down and bottom-up mass spectrometry in conjunction with UniProt annotationsWenrong Chen, Zhengming Ding, Yong Zang, et al.
Human Heredity|February 21, 2007
Robust genomic control and robust delta centralization tests for case-control association studiesYong Zang, Hong Zhang, Yaning Yang, et al.
Journal of Proteome Research|September 20, 2023
Characterization of Proteoform Post-Translational Modifications by Top-Down and Bottom-Up Mass Spectrometry in Conjunction with AnnotationsWenrong Chen, Zhengming Ding, Yong Zang, et al.
Pharmaceutical Statistics|September 26, 2022
A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapyBeibei Guo, Yong Zang, Li-Hsiang Lin, et al.
Analytical Chemistry|May 17, 2023
TopFD: A Proteoform Feature Detection Tool for Top-Down ProteomicsAbdul Rehman Basharat, Yong Zang, Liangliang Sun, et al.
Statistical Methods in Medical Research|March 15, 2023
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effectMu Shan, Beibei Guo, Hao Liu, et al.
Statistics in Biopharmaceutical Research|June 17, 2026
A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab priorsMu Shan, Mengyi Lu, Leng Han, et al.
Statistics in Biopharmaceutical Research|June 17, 2026
An Adaptive Biomarker-based Umbrella Trial Design Using Bayesian Latent Class ModelJiaying Guo, Mengyi Lu, Yan Han, et al.
Pharmaceutical Statistics|March 25, 2022
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trialsYifei Zhang, Beibei Guo, Sha Cao, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Sensors (Basel, Switzerland)|June 9, 2018
Cold-Rolled Strip Steel Stress Detection Technology Based on a Magnetoresistance Sensor and the Magnetoelastic EffectBen Guan, Yong Zang, Xiaohui Han, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Characterization of proteoform post-translational modifications by top-down and bottom-up mass spectrometry in conjunction with UniProt annotationsWenrong Chen, Zhengming Ding, Yong Zang, et al.
Human Heredity|February 21, 2007
Robust genomic control and robust delta centralization tests for case-control association studiesYong Zang, Hong Zhang, Yaning Yang, et al.
Journal of Proteome Research|September 20, 2023
Characterization of Proteoform Post-Translational Modifications by Top-Down and Bottom-Up Mass Spectrometry in Conjunction with AnnotationsWenrong Chen, Zhengming Ding, Yong Zang, et al.
Pharmaceutical Statistics|September 26, 2022
A Bayesian phase I/II design to determine subgroup-specific optimal dose for immunotherapy sequentially combined with radiotherapyBeibei Guo, Yong Zang, Li-Hsiang Lin, et al.
Analytical Chemistry|May 17, 2023
TopFD: A Proteoform Feature Detection Tool for Top-Down ProteomicsAbdul Rehman Basharat, Yong Zang, Liangliang Sun, et al.
Statistical Methods in Medical Research|March 15, 2023
Bayesian order constrained adaptive design for phase II clinical trials evaluating subgroup-specific treatment effectMu Shan, Beibei Guo, Hao Liu, et al.
Statistics in Biopharmaceutical Research|June 17, 2026
A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab priorsMu Shan, Mengyi Lu, Leng Han, et al.
Statistics in Biopharmaceutical Research|June 17, 2026
An Adaptive Biomarker-based Umbrella Trial Design Using Bayesian Latent Class ModelJiaying Guo, Mengyi Lu, Yan Han, et al.
Pharmaceutical Statistics|March 25, 2022
SCI: A Bayesian adaptive phase I/II dose-finding design accounting for semi-competing risks outcomes for immunotherapy trialsYifei Zhang, Beibei Guo, Sha Cao, et al.
Pageof 11